The latest quarterly EBITDA is $240.00 Thousand. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) measures a company's operating performance by removing non-cash charges and capital structure effects.
Q2 FY2028 (2026-07-03).
Reported quarterly EBITDA; no daily interpolation. Q2 FY2028 (2026-07-03): $240000.00.
EBITDA growth vs the same fiscal quarter in the prior fiscal year, last 9 comparable quarters.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T22:25:38.967Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
$240.00K
$240.00 Thousand
Q2 FY2028 · 2026-07-03
N/A
16
Quarters of data available
| Period | EBITDA | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2028Period end 2026-07-03 | $240.00K | N/A | N/A |
| Q1 FY2028Period end 2026-04-03 | −$499.00K | N/A | +91.97% |
| Q4 FY2027Period end 2026-01-02 | $2.26M | N/A | N/A |
| Q3 FY2027Period end 2025-10-03 | −$372.00K | +89.84% | N/A |
| Q2 FY2027Period end 2025-07-04 | −$3.66M | +41.03% | +91.71% |
| Q1 FY2027Period end 2025-04-04 | −$6.21M | +82.53% | +77.31% |
| Q4 FY2026Period end 2025-01-03 | −$35.55M | N/A | -207.03% |
| Q3 FY2026Period end 2024-09-27 | $2.65M | N/A | -93.37% |
| Q2 FY2026Period end 2024-06-28 | −$44.20M | -61.44% | -636.75% |
| Q1 FY2026Period end 2024-03-29 | −$27.38M | -136.49% | -466.89% |
| Q4 FY2025Period end 2023-12-29 | −$11.58M | N/A | +17.62% |
| Q3 FY2025Period end 2023-09-29 | $39.96M | N/A | +88.58% |
| Q2 FY2025Period end 2023-06-30 | −$6.00M | -24.22% | N/A |
| Q1 FY2025Period end 2023-03-31 | −$4.83M | +65.64% | N/A |
| Q4 FY2024Period end 2022-12-31 | −$14.05M | N/A | N/A |
| Q3 FY2024Period end 2022-09-30 | $21.19M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
